1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with inosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osswald, W | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Mi, Z | 1 |
2 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and inosine
| Article | Year |
|---|---|
Mediation by adenosine of the trophic effects exerted by the sympathetic innervation of blood vessels.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dogs; Inosine; Muscle Denervation; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Purinergic Antagonists; Receptors, Purinergic; Reference Values; Saphenous Vein; Sympathectomy; Sympathectomy, Chemical; Vasodilator Agents; Xanthines | 1991 |
Cardiac fibroblasts express the cAMP-adenosine pathway.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine Monophosphate; Analysis of Variance; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Extracellular Space; Fibroblasts; Inosine; Male; Myocardium; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 2000 |